Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet

Author:

Lékó András H.,Gregory-Flores Adriana,Marchette Renata C. N.ORCID,Gomez Juan L.,Vendruscolo Janaina C. M.,Repunte-Canonigo Vez,Choung VickyORCID,Deschaine Sara L.,Whiting Kimberly E.,Jackson Shelley N.,Cornejo Maria Paula,Perello Mario,You Zhi-Bing,Eckhaus Michael,Rasineni Karuna,Janda Kim D.ORCID,Zorman Barry,Sumazin PavelORCID,Koob George F.,Michaelides MichaelORCID,Sanna Pietro P.ORCID,Vendruscolo Leandro F.ORCID,Leggio LorenzoORCID

Abstract

AbstractThe stomach-derived hormone ghrelin regulates essential physiological functions. The ghrelin receptor (GHSR) has ligand-independent actions; therefore, GHSR gene deletion may be a reasonable approach to investigate the role of this system in feeding behaviors and diet-induced obesity (DIO). Here, we investigate the effects of a long-term (12-month) high-fat (HFD) versus regular diet on obesity-related measures in global GHSR-KO and wild-type (WT) Wistar male and female rats. Our main findings are that the GHSR gene deletion protects against DIO and decreases food intake during HFD in male but not in female rats. GHSR gene deletion increases thermogenesis and brain glucose uptake in male rats and modifies the effects of HFD on brain glucose metabolism in a sex-specific manner, as assessed with small animal positron emission tomography. We use RNA-sequencing to show that GHSR-KO rats have upregulated expression of genes responsible for fat oxidation in brown adipose tissue. Central administration of a novel GHSR inverse agonist, PF-5190457, attenuates ghrelin-induced food intake, but only in male, not in female mice. HFD-induced binge-like eating is reduced by inverse agonism in both sexes. Our results support GHSR as a promising target for new pharmacotherapies for obesity.

Funder

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism

Publisher

Springer Science and Business Media LLC

Reference112 articles.

1. Hales, C. M., Carroll, M. D., Fryar, C. D. & Ogden, C. L. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, National Center for Health Statistics 360, 1–7 (2020).

2. WHO Obesity and overweight, https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (2021).

3. Deschaine, S. L. & Leggio, L. From “Hunger Hormone” to “It’s Complicated”: Ghrelin beyond feeding control. Physiology 37, 5–15 (2022).

4. Zallar, L. J., Farokhnia, M., Tunstall, B. J., Vendruscolo, L. F. & Leggio, L. The role of the Ghrelin system in drug addiction. Int. Rev. Neurobiol. 136, 89–119 (2017).

5. Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3